Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
Blastomycosis D001759 5 associated lipids
Aspergillosis D001228 5 associated lipids
Xerostomia D014987 6 associated lipids
Vaginitis D014627 6 associated lipids
Gonorrhea D006069 7 associated lipids
Otitis Externa D010032 8 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Influenza, Human D007251 11 associated lipids
HIV Seropositivity D006679 15 associated lipids
Dermatomycoses D003881 17 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Burns D002056 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Peritonitis D010538 38 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Hemolysis D006461 131 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Woods O and Saliba I Effect of nystatin on Guinea Pigs' inner ear. 2011 Neurotox Res pmid:21384237
Harata N et al. Excitatory amino acid responses in relay neurons of the rat lateral geniculate nucleus. 1999 Neuroscience pmid:10051221
Thoreson WB Dihydropyridine-sensitive calcium currents in bipolar cells of salamander retina are inhibited by reductions in extracellular chloride. 2000 Neurosci. Lett. pmid:10675784
Nabekura J et al. Developmental change of the potentiation of NMDA response by spermine. 1995 Neuroreport pmid:7543301
Arata A et al. Possible synaptic connections of expiratory neurons in the medulla of newborn rat in vitro. 1998 Neuroreport pmid:9559949
Ishibashi H et al. Inhibition of the 5-HT(1A) receptor-mediated inwardly rectifying K(+) current by dextromethorphan in rat dorsal raphe neurones. 2000 Neuropharmacology pmid:10974313
Hahn SJ et al. Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells. 1996 Neuropharmacology pmid:8938720
Chow RH et al. Mechanisms determining the time course of secretion in neuroendocrine cells. 1996 Neuron pmid:8789951
Hull C and von Gersdorff H Fast endocytosis is inhibited by GABA-mediated chloride influx at a presynaptic terminal. 2004 Neuron pmid:15504327
Heyward PM et al. Inward membrane currents and electrophysiological responses to GnRH in ovine gonadotropes. 1995 Neuroendocrinology pmid:7544876
Hu R et al. Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies. 2013 Neoplasma pmid:23374002
Shin MC et al. A selective T-type Ca2+ channel blocker R(-) efonidipine. 2008 Naunyn Schmiedebergs Arch. Pharmacol. pmid:18278483
Levitan ES and Kramer RH Neuropeptide modulation of single calcium and potassium channels detected with a new patch clamp configuration. 1990 Nature pmid:2174131
Giaever G et al. Functional profiling of the Saccharomyces cerevisiae genome. 2002 Nature pmid:12140549
Khan A et al. A new triterpenoid from roots of Laportea crenulata and its antifungal activity. 2007 Nat. Prod. Res. pmid:17691044
Grassmé H et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. 2003 Nat. Med. pmid:12563314
Anderson HA et al. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. 2000 Nat. Immunol. pmid:11248809
Shi L et al. Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. 2013 Nat Commun pmid:23385580
Gerstein AC et al. Loss-of-heterozygosity facilitates passage through Haldane's sieve for Saccharomyces cerevisiae undergoing adaptation. 2014 Nat Commun pmid:24804896
Al-Jubory AR and Handy RD Uptake of titanium from TiOâ‚‚ nanoparticle exposure in the isolated perfused intestine of rainbow trout: nystatin, vanadate and novel COâ‚‚-sensitive components. 2013 Nanotoxicology pmid:23020080
Marmiroli M et al. A genome-wide nanotoxicology screen of Saccharomyces cerevisiae mutants reveals the basis for cadmium sulphide quantum dot tolerance and sensitivity. 2016 Nanotoxicology pmid:25938282
Wang MM et al. Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process. 2015 Nanotoxicology pmid:25676621
Bhattacharya S et al. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. 2012 Nano Lett. pmid:22375622
FEINGOLD DS ANTIMICROBIAL CHEMOTHERAPEUTIC AGENTS: THE NATURE OF THEIR ACTION AND SELECTIVE TOXICITY. 1963 N. Engl. J. Med. pmid:14050990
Dismukes WE et al. A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. 1990 N. Engl. J. Med. pmid:2247104
Bennett JE Searching for the yeast connection. 1990 N. Engl. J. Med. pmid:2247107
Casalaz D Fluconazole prophylaxis against fungal infection in preterm infants. 2002 N. Engl. J. Med. pmid:12066811
A controlled trial of nystatin for the candidiasis hypersensitivity syndrome. 1991 N. Engl. J. Med. pmid:2027363
Wade JC et al. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. 1981 N. Engl. J. Med. pmid:6782486
Ozturk MA et al. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. 2006 Mycoses pmid:17022766
Abu-Elteen KH Incidence and distribution of Candida species isolated from human skin in Jordan. 1999 Mycoses pmid:10424102
Messier C and Grenier D Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. 2011 Mycoses pmid:21615543
Mousa HA and al-Bader SM Yeast infection of burns. 2001 Mycoses pmid:11486451
Fernández-Campos F et al. Evaluation of novel nystatin nanoemulsion for skin candidosis infections. 2013 Mycoses pmid:22574899
Blaschke-Hellmessen R and Schwarze U Bioassay for determination of nystatin in faeces after oral application. 1990 Mycoses pmid:2113608
Müller J [Electron microscopy of Candida albicans]. 1999 Mycoses pmid:10592709
Monteiro DR et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. 2013 Mycoses pmid:23773119
Ellepola AN et al. The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. 2014 Mycoses pmid:23773155
Hoppe JE et al. Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes. 1995 Jan-Feb Mycoses pmid:7637681
Auger P et al. Treatment of cutaneous candidosis in guinea pigs: effect of zinc oxide on the antifungal efficacy of nystatin. 1989 Mycoses pmid:2608092
Li D et al. Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. 2014 Mycoses pmid:23952962
Ohnemus U et al. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. 2008 Mycoses pmid:18076591
Preissner S et al. Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. 2016 Mycoses pmid:26932256
Schäfer-Korting M et al. Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk. 1996 Sep-Oct Mycoses pmid:9009654
Boon JM et al. Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis. 1989 Mycoses pmid:2779612
Blaschke-Hellmessen R et al. [Effect of orally administered polyene antimycotics on the intestinal colonization with yeasts: possibilities and limitations]. 1996 Mycoses pmid:8767267
Broughton MC et al. Polyene resistance in ergosterol producing strains of Candida albicans. 1991 Jan-Feb Mycoses pmid:1922193
Knoke M [Clinical pictures of orointestinal candidiasis. Fiction or reality?]. 1996 Mycoses pmid:8767268
Kunzelmann V et al. [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis]. 1996 Mycoses pmid:8767274
Sharifzadeh A et al. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. 2015 Mycoses pmid:26152466